US Patent Issued to Theripion on June 17 for "APOA-1 fusion polypeptides and related compositions" (Washington Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,102, issued on June 17, was assigned to Theripion Inc. (Shoreline, Wash.).

"APOA-1 fusion polypeptides and related compositions" was invented by Martha S. Hayden-Ledbetter (Shoreline, Wash.) and Jeffrey A. Ledbetter (Shoreline, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods relating to ApoA-1 fusion polypeptides are disclosed. The fusion polypeptides include a first polypeptide segment corresponding to an ApoA-1 polypeptide or ApoA-1 mimetic, and may also include a dimerizing domain such as, e.g., an Fc region, which is typically linked carboxyl-terminal to the first polypeptide segment via a flexible linker. In some e...